Primary performance measures | |
---|---|
During hospitalization | |
 Proportion of patients receiving aspirin at arrival  Proportion of patients receiving P2Y12 inhibitor at arrival  Proportion of patients arrival by emergency ambulance  Proportion of patients receiving early reperfusion therapy  Proportion of patients receiving fibrinolytic therapy within 30 min of first medical contact among those receiving this treatment  Proportion of patients receiving primary PCI within 90 min of first medical contact among those receiving this treatment  Proportion of patients with evaluation of left ventricular function by echocardiography | |
At discharge | |
 Proportion of patients receiving aspirin at discharge  Proportion of patients receiving P2Y12 inhibitor at discharge  Proportion of patients receiving statin at discharge  Proportion of patients with indications receiving a β-blocker at discharge  Proportion of patients with indications receiving an ACEI or ARB at discharge  In-hospital all-cause mortality  In-hospital death or treatment withdrawal  In-hospital MACCE (death, congestive heart failure, reinfarction and ischemic stroke) | |
Follow-up | |
 Proportion of patients receiving 1-month on-time follow-up  Proportion of patients receiving 6-month on-time follow-up  Proportion of patients receiving 1-year on-time follow-up | |
Secondary performance measures | |
 Proportion of patients receiving first ECG within 10 min of first medical contact  Proportion of delayed primary PCI (Time from first medical contact to primary PCI > 90 min)  Proportion of patients receiving anticoagulants at arrival (within 24 h)  Proportion of patients receiving determination of blood LDL level  Proportion of patients receiving P2Y12 inhibitor at discharge among those receiving reperfusion  Proportion of patients receiving P2Y12 inhibitor at discharge among those without receiving reperfusion  Proportion of patients receiving aspirin and P2Y12 inhibitor at discharge |